Drug recall · February 21, 2018
Fluoxetine Tablets USP recall
Why: Failed impurities/ degradation specifications: Teva Pharmaceuticals USA, Inc. is voluntarily recalling all lots within expiry due to out of specification (OOS) test result for the lactoside impurity obtained during routine stability testing activities.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Fluoxetine Tablets USP, 10 mg, 30-count bottle, Rx only, Manufactured in Israel by: Teva Pharmaceuticals IND, LTD, Jerusalem, 9777402, Israel, Manufactured for: Teva Pharmaceuticals USA, INC., North Wales, PA 19454, NDC 0093-7188-56
- Lots / codes
All lots within expiry.
- Quantity
- 1,157,095 bottles
- Company
- Teva Pharmaceuticals USA, North Wales, PA
- Distribution
- Distributed throughout the United States
- Initiated
- February 5, 2018 · Voluntary: Firm initiated
- Classified
- March 5, 2018
- Reported
- February 21, 2018
- Ended
- April 30, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fluoxetine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.